Multifocal electroretinography as a predictor of maintenance of vision after photodynamic therapy for neovascular age-related macular degeneration
- 21 September 2007
- journal article
- Published by Springer Science and Business Media LLC in Documenta Ophthalmologica
- Vol. 116 (1), 13-18
- https://doi.org/10.1007/s10633-007-9071-z
Abstract
To investigate the role of multifocal electroretinography (mfERG) in predicting the outcome of photodynamic therapy (PDT) for neovascular age-related macular degeneration (AMD). Participants underwent refraction protocol VA assessment using the ETDRS logMAR chart at 1 m, Contrast Sensitivity (CS) using the Pelli-Robson chart at 1 m, fundus fluorescein angiography (FA) and mfERGs in response to 19 segments. Response to PDT was binary (1 = the loss of less than 15 letters at 12 months, 0 = the loss of 15 letters or more) and was used as the dependent variable for logistic regression analysis. Logistic regression modelling identified mfERG central segment amplitude, lesion size on FA, VA and CS as predictors of outcome (P = 0.05, 0.02, 0.01, 0.03). The model is stable and has excellent discriminability. The outcomes of this study are particularly relevant to patients in the UK who are sometimes treated with PDT alone. A larger prospective study would facilitate development of an index to predict outcome of future treatments for AMD.Keywords
This publication has 19 references indexed in Scilit:
- Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapyDocumenta Ophthalmologica, 2007
- A comparison of pattern and multifocal electroretinography in the evaluation of age-related macular degeneration and its treatment with photodynamic therapyDocumenta Ophthalmologica, 2006
- Examination of short binary sequences for mfERG recordingDocumenta Ophthalmologica, 2006
- Does lesion size determine the success rate of photodynamic therapy for age-related macular degeneration?Eye, 2005
- Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degenerationBritish Journal of Ophthalmology, 2005
- Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patternsAmerican Journal of Ophthalmology, 2004
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1American Journal of Ophthalmology, 2003
- Veränderungen neovaskulärer Membranen und normaler Aderhautgefäße nach mehrfacher photodynamischer TherapieDer Ophthalmologe, 2002
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinAmerican Journal of Ophthalmology, 1999
- Early Treatment Diabetic Retinopathy Study Design and Baseline Patient CharacteristicsOphthalmology, 1991